Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, octubre 06
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Dr Reddy's Laboratories Ltd
RDY
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$12.32
0.07
0.57%
Últ. Act.: Oct 5, 4:00 PM
$12.32
0.07
0.57%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Dividendos
Comparar
Opciones
Informe de acciones
Privacy Manager
Dr Reddy's Laboratories Financials
Dr Reddy's Laboratories (RDY) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Why Dr. Reddy's Sank: Profit Plunge, Semaglutide Setback And Trump's Tariff Threat
Dr. Reddy's (RDY) stock drops after missing Q1 FY27 earnings & revenue estimates. Semaglutide issues & Trump tariff plans weigh on shares.
Vandana Singh
PRO
Dr Reddy's Laboratories Q1 EPS $0.06 Misses $0.17 Estimate, Sales $853.000M Miss $925.530M Estimate
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.17 by 64.71 percent. This is a 70 percent decrease over earnings of $0.20 per share
Benzinga Newsdesk
Earnings Scheduled For July 22, 2026
Companies Reporting Before The Bell • Northern Trust (NASDAQ:NTRS) is expected to report quarterly earnings at $3.45 per share on revenue of $2.35 billion. • Old National Bancorp (NASDAQ:ONB) is projected to report
Benzinga Insights
PRO
Dr Reddy's Laboratories Q4 EPS $0.03 Misses $0.09 Estimate, Sales $821.821M Miss $866.120M Estimate
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.09 by 66.67 percent. This is a 86.36 percent decrease over earnings of $0.22 per share
Benzinga Newsdesk
Earnings Scheduled For May 12, 2026
Benzinga Insights
PRO
Dr Reddy's Laboratories Q3 EPS $0.16, Inline, Sales $978.820M Beat $978.100M Estimate
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 18.5 percent decrease over earnings of $0.20 per share from the same period last year.
Benzinga Newsdesk
